Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus).
Nomura K, Watanabe T, Takamori S, Hamada A, Suda K, Ito M, Ohara S, Oiki H, Fukami T, Muto S, Katsumata S, Konno H, Hayasaka K, Toyoda T, Endo M, Takamori S, Nakatsuka M, Tenpaku H, Takegahara K, Matsubara T, Kinoshita F, Akamine T, Nakamura R, Mizuno K, Nakagawa K, Kaneda S, Okada S, Kosai K, Notsuda H, Sakane T, Shinohara S, Abe M, Haratake N, Tane S, Hanawa R, Tarukawa T, Namba K, Toda M, Kawaguchi T, Takada K, Minegishi K, Kurihara N, Iguchi T, Aokage K, Tsutani Y, Tsuboi M, Soh J, Shimokawa M, Ohde Y.
Nomura K, et al.
Ann Thorac Surg. 2026 Jun;121(6):1338-1346. doi: 10.1016/j.athoracsur.2025.09.054. Epub 2025 Oct 30.
Ann Thorac Surg. 2026.
PMID: 41173344